Song J, Bai L, Zhai J, Xin Z, et al. Allele frequency and proportion defined by circulating tumor DNA profiling predict tyrosine kinase inhibitors' therapeutic outcomes for non-small cell lung cancer. J Cancer Res Clin Oncol 2022 May 17. pii: 10.1007/s00432-022-03992.
PMID: 35578031